BofA Upgrades United Rentals, Says COVID Vaccine A Potential 'Cure' For Industry

A potential vaccine against COVID-19 is a potential "cure" for non-residential equipment rental companies like United Rentals, Inc. URI, according to BofA Securities.

The United Rentals Analyst: Ross Gilardi upgraded United Rentals' stock from Neutral to Buy with a price target lifted from $209 to $275.

The United Rentals Thesis: Gilardi said United Rentals' direct exposure to construction and industrial customers, utilities and municipalities bode well ahead of a potential COVID-19 vaccine. Specifically, industrial production is showing signs of a rebound while rental time utilization is recovering.

While encouraging, there aren't enough "pockets of strength" to support a rebound and this is where the vaccine fits into the bullish narrative.

Industrial MRO (35% of rental revenue) should benefit the most from pent up maintenance needs while urban infrastructure maintenance projects on hold could pick up after the vaccine.

Meanwhile, management's tone during its third-quarter earnings conference sounded "a little more positive" on capital spending. The company isn't committing to any specific number but expectations for a repeat of $900 million in gross capital spending "seems very low."

Encouragingly, Gilardi said United Rentals' stock starts to outperform when capital spending reaches a bottom. While the outperformance already started, the stock still has upside potential as "we think the bias is upwards on capex in 2021."

URI Price Action: Shares of United Rentals were trading higher by 1.7% Friday morning at $220.80.

Photo credit: Adam Keethler, via Wikimedia Commons

URI Logo
URIUnited Rentals Inc
$647.369.87%

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score
Edge Rankings
Momentum
25.36
Growth
67.56
Quality
-
Value
11.32
Price Trend
Short
Medium
Long
Market News and Data brought to you by Benzinga APIs
date
ticker
name
Price Target
Upside/Downside
Recommendation
Firm

Posted In:
Comments
Loading...